Differences in the Volatilomic Urinary Biosignature of Prostate Cancer Patients as a Feasibility Study for the Detection of Potential Biomarkers.

Prostate cancer (PCa) continues to be the second most common malignant tumour and the main cause of oncological death in men. Investigating endogenous volatile organic metabolites (VOMs) produced by various metabolic pathways is emerging as a novel, effective, and non-invasive source of information...

Descripción completa

Detalles Bibliográficos

Publicado en:	Current Oncology Vol. 30; no. 5; pp. 4904 - 4922
Autores principales:	Riccio, Giulia, Berenguer, Cristina V., Perestrelo, Rosa, Pereira, Ferdinando, Berenguer, Pedro, Ornelas, Cristina P., Sousa, Ana Célia, Vital, João Aragão, Pinto, Maria do Carmo, Pereira, Jorge A. M., Greco, Viviana, Câmara, José S.
Formato:	Journal Article
Publicado:	MDPI May2023
Acceso en línea:	Ver este registro en EBSCOhost